Seoul, Korea - Asia's most comprehensive interventional cardiology conference will kick off next month and feature special debates and lectures by renowned cardiologists from around the world.
TCTAP & AP VALVES 2020 VIRTUAL will open its recorded sessions to the public starting August 6 to August 8. Registration is free and accessible via the TCTAP & AP VALVES 2020 VIRTUAL homepage.
Funded by the CardioVascular Research Foundation (CVRF) and hosted by Asan Medical Center (AMC), TCTAP & AP VALVES 2020 VIRTUAL is a new academic conference that blends the TCTAP conference and the AP VALVES conference – both of which were traditionally hosted separately.
The decision to blend the two is a bold move the conference Co-Chair and Program Director Park Duk-woo, AMC Professor of Cardiology made in light of the COVID-19 pandemic.
“The team in charge of organizing the conference spent the past six months trying to find out the best platforms and methods to host our programs during the COVID-19 pandemic,” Park said in an interview with The Medical Observer. “In the end, we decided to go 100 percent virtual considering more than half of our participants were abroad.”
“Despite the hardships brought on by COVID-19, TCTAP & AP VALVES 2020 VIRTUAL will move forward stronger than ever as the first large-scale, full-scale online international academic conference hosted in Korea,” Park added.
This year, TCTAP & AP VALVES 2020 VIRTUAL will feature a special debate session on percutaneous coronary intervention (PCI) versus coronary artery bypass graft (CABG) in left main disease – one of the most controversial areas of cardiology.
The session will be packed with a fierce debate between world-renowned cardiologists.
The debate – moderated by Saint Joseph's Health System’s Spencer B. King and University Hospital Birmingham-Queen Elizabeth’s Domenico Pagano – will feature AMC’s Park Seung-jung facing off with University of Oxford’s David Paul Taggart over PCI vs. CABG in left main disease.
Aside from PCI vs. CABG, TCTAP & AP VALVES 2020 VIRTUAL will also showcase COVID-19 therapy and vaccine lectures by Cedars-Sinai Medical Center Jonathan Grein and Walter Reed Army Institute of Research (WRAIR)’s Kayvon Modjarrad.
Researchers will also present the latest equipment and technology in the field of cardiac intervention such as the MitraClip – which was introduced in Korea earlier this year – as well as tricuspid intervention, which is not yet available domestically.
World-leading researchers will also present lectures on controversial areas of transcatheter aortic valve implantation (TAVI) as well as other fields of interventional cardiology.
“Although it may be difficult to proceed with academic conferences as before, I believe it’s essential that we continue learning and growing – TCTAP & AP VALVES 2020 VIRTUAL evolved in light of the changing times and strives to meet this academic need,” Park said.